Results 371 to 380 of about 5,260,709 (398)
Real‑world application of Cytalux for targeted imaging of occult peritoneal disease in epithelial ovarian cancer. [PDF]
Mol Clin OncolBaron E +4 more
europepmc +1 more source
Enhancing ovarian cancer treatment by synergistically targeting HER2 and PD-L1. [PDF]
Mol Ther OncolZhang S, Pan Q, Wang K.
europepmc +1 more source
Enhancing the efficiency of oncolytic vaccinia virus for ovarian cancer treatment
Drymiotou S +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
International Journal of Cancer, 2022
Ovarian cancer remains to have relatively poor prognosis particularly in low‐resourced settings. It is therefore important to continually examine the burden of ovarian cancer to identify areas of disparities.
C. Cabasag +8 more
semanticscholar +1 more source
Ovarian cancer remains to have relatively poor prognosis particularly in low‐resourced settings. It is therefore important to continually examine the burden of ovarian cancer to identify areas of disparities.
C. Cabasag +8 more
semanticscholar +1 more source
Critical Reviews in Oncology/Hematology, 2006
Ovarian cancer accounts for 4% of all cancers in women and is the leading cause of death from gynaecologic malignancies. Because early-stage ovarian cancer is generally asymptomatic, approximately 75% of women present with advanced disease at diagnosis. Survival is highly dependent on stage of disease: 5-year survival in patients with early-stage is 80-
Pat J. Morin, Ellen S. Pizer
openaire +3 more sources
Ovarian cancer accounts for 4% of all cancers in women and is the leading cause of death from gynaecologic malignancies. Because early-stage ovarian cancer is generally asymptomatic, approximately 75% of women present with advanced disease at diagnosis. Survival is highly dependent on stage of disease: 5-year survival in patients with early-stage is 80-
Pat J. Morin, Ellen S. Pizer
openaire +3 more sources
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.
Science, 1989Carcinoma of the breast and ovary account for one-third of all cancers occurring in women and together are responsible for approximately one-quarter of cancer-related deaths in females.
D. Slamon +10 more
semanticscholar +1 more source
British Journal of Cancer, 1993
Mice have been used in ovarian cancer research mainly as hosts for cell lines derived from human ovarian tumors and ascites. Such models provided valuable information into the nature of metastatic ovarian cancer and possible treatment strategies. However,
S. Orsulic
semanticscholar +1 more source
Mice have been used in ovarian cancer research mainly as hosts for cell lines derived from human ovarian tumors and ascites. Such models provided valuable information into the nature of metastatic ovarian cancer and possible treatment strategies. However,
S. Orsulic
semanticscholar +1 more source
Surgical Oncology Clinics of North America, 1998
Ovarian cancer is the leading cause of death in women with pelvic malignancies. Because of the multiple histologic types of malignancy that can arise within the ovary, accurate diagnosis and staging is critical for optimal patient care. The current standard of proper surgical management followed by combination chemotherapy is outlined.
W, Gajewski, R D, Legare
openaire +2 more sources
Ovarian cancer is the leading cause of death in women with pelvic malignancies. Because of the multiple histologic types of malignancy that can arise within the ovary, accurate diagnosis and staging is critical for optimal patient care. The current standard of proper surgical management followed by combination chemotherapy is outlined.
W, Gajewski, R D, Legare
openaire +2 more sources